Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease

Background. Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronically remittent and progressive inflammatory disorders. Phospholipase D2 (PLD2) is reported to be involved in the pathogenesis of several inflammatory diseases. However, the exac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Guangxi, Yu, Lin, Yang, Wenjing, Wu, Wei, Fang, Leilei, Liu, Zhanju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046040/
https://www.ncbi.nlm.nih.gov/pubmed/27721573
http://dx.doi.org/10.1155/2016/2543070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046040/
https://www.ncbi.nlm.nih.gov/pubmed/27721573
http://dx.doi.org/10.1155/2016/2543070

Ejemplares similares